Ronit Capital LLP Mesoblast LTD Transaction History
Ronit Capital LLP
- $74.3 Million
- Q3 2022
A detailed history of Ronit Capital LLP transactions in Mesoblast LTD stock. As of the latest transaction made, Ronit Capital LLP holds 150,000 shares of MESO stock, worth $1.7 Million. This represents 0.51% of its overall portfolio holdings.
Number of Shares
150,000Holding current value
$1.7 Million% of portfolio
0.51%Shares
1 transactions
Others Institutions Holding MESO
# of Institutions
3Shares Held
151KCall Options Held
0Put Options Held
0About MESOBLAST LTD
- Ticker MESO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 147,316,000
- Market Cap $1.67B
- Description
- Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...